Organicell Regenerative Medicine, Inc. (OCEL) has 8 open-market insider trades by 4 insiders since 2015. The most active filer is Harry L. Leider, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Harry L. Leider | CEO | — | 3 | $72K | 2023-12-19 |
| Skycrest Holdings, LLC | 10% | — | 3 | $17K | 2023-07-07 |
| Matthew Phillip Sinnreich | Pres | — | 1 | $800 | 2022-10-31 |
| Ricardo Prats | CEOPresCFOTreasurer10% | — | 1 | $600 | 2015-02-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Harry L. Leider | CEO | Sell | $7K | 2023-12-19 |
| Skycrest Holdings, LLC | 10% | Buy | $3K | 2023-07-07 |
| Skycrest Holdings, LLC | 10% | Buy | $6K | 2023-06-28 |
| Harry L. Leider | CEO | Buy | $60K | 2023-06-28 |
| Harry L. Leider | CEO | Buy | $5K | 2023-06-28 |
| Skycrest Holdings, LLC | 10% | Buy | $8K | 2023-06-26 |
Companies that share insiders with OCEL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Matthew Phillip Sinnreich | President | Sell | $800 | 2022-10-13 |
| Ricardo Prats | CEO & President +3 | Sell | $600 | 2015-02-09 |